The next-generation gynecological cancer diagnostics market size is expected to see rapid growth in the next few years. It will grow to $4.07 billion in 2028 at a compound annual growth rate (CAGR) of 11.0%. The growth in the forecast period can be attributed to precision medicine and targeted therapies, integration of artificial intelligence (ai), liquid biopsy adoption, expansion of point-of-care testing, widespread implementation of 3d imaging, rise of telemedicine in cancer care. Major trends in the forecast period include patient-centric diagnostics, comprehensive biomarker panels, integration of wearable devices, collaborations and consortia, advances in imaging modalities.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/next-generation-gynecological-cancer-diagnostics-global-market-report
Segmentation & Regional Insights
The next-generation gynecological cancer diagnostics market covered in this report is segmented –
1) By Cancer Type: Cervical Cancer, Ovarian Cancer, Uterine Cancer, Vaginal Cancer, Vulvar Cancer
2) By Function: Therapeutic Monitoring, Companion Diagnostics, Prognostics, Cancer Screening, Risk Analysis
3) By Technology: Next-Generation Sequencing, qPCR And Multiplexing, Lab-on- a- chip (LOAC) And Reverse Transcriptase-PCR (RT-PCR), Protein Microarrays, DNA Microarrays
4) By Application: Biomarker Development, CTC Analysis, Proteomic Analysis, Epigenetic Analysis, Genetic Analysis
5) By End User: Hospitals and Ambulatory Centers, Diagnostic Laboratories, Academic and Research Institutes
North Americ a was the largest region in the next-generation gynecological cancer diagnostics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the next-generation gynecological cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12020&type=smp
Major Driver Impacting Market Growth
The rising prevalence of gynecological malignancies is expected to propel the growth of the next-generation gynecological cancer diagnostics market. Gynecological malignancies refer to cancers that occur in the reproductive organs of females, such as the cervix, uterus, ovaries, fallopian tubes, and vulva. The next-generation gynecological cancer diagnostics help reduce gynecological malignancies by allowing for earlier detection of cancerous cells, facilitating targeted treatments, and improving overall patient outcomes. For Instance, in February 2023, according to the National Cancer Institute, a US-based Department of Health and Human Services, around 13,960 American women are anticipated to have an aggressive cervical cancer diagnosis, and 4,310 fatalities from this illness are expected in 2023 in the US. Further, 7.7 per 100,000 women per year new cases of cervical cancer were diagnosed, with an annual death rate of 2.2 per 100,000 females. Therefore, the rising prevalence of gynecological malignancies is driving the growth of the next-generation gynecological cancer diagnostics market.
Key Industry Players
Major companies operating in the next-generation gynecological cancer diagnostics market report are F. Hoffmann-La Roche Ltd., AbbVie Inc., Novartis AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Janssen Global Services LLC, Siemens Healthcare GmbH, Agena Bioscience Inc., Koninklijke Philips N.V., Becton, Dickinson and Company, GE HealthCare Technologies Inc., Laboratory Corporation Of America Holdings, Quest Diagnostics Incorporated, Agilent Technologies Inc., Konica Minolta Inc., Hologic Inc., Illumina Inc., PerkinElmer Inc., Sysmex Corporation, Qiagen N.V., ARUP Laboratories, Almac Group, BGI Genomics Co Ltd, OPKO HEALTH Inc., BGI Genomics Co. Ltd., Myriad Genetics Inc., Fulgent Genetics Inc., Cepheid, Invitae Corporation, Centogene NV
The next-generation gynecological cancer diagnostics market report table of contents includes:
1. Executive Summary
2. Next-Generation Gynecological Cancer Diagnostics Market Characteristics
3. Next-Generation Gynecological Cancer Diagnostics Market Trends And Strategies
4. Next-Generation Gynecological Cancer Diagnostics Market – Macro Economic Scenario
5. Global Next-Generation Gynecological Cancer Diagnostics Market Size and Growth
…………………………………
32. Global Next-Generation Gynecological Cancer Diagnostics Market Competitive Benchmarking
33. Global Next-Generation Gynecological Cancer Diagnostics Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Next-Generation Gynecological Cancer Diagnostics Market
35. Next-Generation Gynecological Cancer Diagnostics Market Future Outlook and Potential Analysis
36. Appendix
Explore the trending research reports from TBRC:
https://goodprnews.com/ferrochrome-global-market-size/
https://goodprnews.com/formic-acid-global-market-share/
https://goodprnews.com/greenhouse-horticulture-global-market-size/
https://topprnews.com/ferrochrome-global-market-share/
https://topprnews.com/formic-acid-global-market-size/
https://topprnews.com/greenhouse-horticulture-global-market-share/
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
